BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 28249297)

  • 21. Flow-directed atrial catheter placement for ventriculoatrial shunts: technical note.
    Barker FG; Tatter SB
    Neurosurgery; 1994 Sep; 35(3):534-5; discussion 535-6. PubMed ID: 7800150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The British antibiotic and silver-impregnated catheters for ventriculoperitoneal shunts multi-centre randomised controlled trial (the BASICS trial): study protocol.
    Jenkinson MD; Gamble C; Hartley JC; Hickey H; Hughes D; Blundell M; Griffiths MJ; Solomon T; Mallucci CL
    Trials; 2014 Jan; 15():4. PubMed ID: 24383496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross my heart: ventriculoatrial shunt migration into the pulmonary arteries.
    Torres-Brunet L; Pérez-Bovet J; Cohn Reinoso C; Joly Torta MC; Rimbau-Muñoz J
    Br J Neurosurg; 2023 Jun; 37(3):298-299. PubMed ID: 31916457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrocephalus and shunts in children with brain tumors.
    Ryan JA; Shiminski-Maher T
    J Pediatr Oncol Nurs; 1995 Oct; 12(4):223-9. PubMed ID: 7495527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complications of CSF Shunts in Pediatrics: Functional Assessment With CSF Shunt Scintigraphy-Performance and Interpretation.
    Khalatbari H; Parisi MT
    AJR Am J Roentgenol; 2020 Dec; 215(6):1474-1489. PubMed ID: 33084363
    [No Abstract]   [Full Text] [Related]  

  • 26. Prior CSF shunting increases the risk of endoscopic third ventriculostomy failure in the treatment of obstructive hydrocephalus in adults.
    Woodworth G; McGirt MJ; Thomas G; Williams MA; Rigamonti D
    Neurol Res; 2007 Jan; 29(1):27-31. PubMed ID: 17427271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid diversion procedures.
    Garton HJ
    J Neuroophthalmol; 2004 Jun; 24(2):146-55. PubMed ID: 15179069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of ventricular catheter obstruction and slit ventricle syndrome by the prophylactic use of the Integra antisiphon device in shunt therapy for pediatric hypertensive hydrocephalus: a 25-year follow-up study.
    Gruber RW; Roehrig B
    J Neurosurg Pediatr; 2010 Jan; 5(1):4-16. PubMed ID: 20043731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns in neurosurgical adverse events: cerebrospinal fluid shunt surgery.
    Wong JM; Ziewacz JE; Ho AL; Panchmatia JR; Bader AM; Garton HJ; Laws ER; Gawande AA
    Neurosurg Focus; 2012 Nov; 33(5):E13. PubMed ID: 23116093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standardization of cerebrospinal fluid shunt valves in pediatric hydrocephalus: an analysis of cost, operative time, length of stay, and shunt failure.
    Berns J; Priddy B; Belal A; Seibold RD; Zieles K; Jea A
    J Neurosurg Pediatr; 2021 Jan; 27(4):400-405. PubMed ID: 33513571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraoperative ultrasound guidance for the placement of permanent ventricular cerebrospinal fluid shunt catheters: a single-center historical cohort study.
    Crowley RW; Dumont AS; Asthagiri AR; Torner JC; Medel R; Jane JA; Jane JA; Kassell NF
    World Neurosurg; 2014 Feb; 81(2):397-403. PubMed ID: 23321382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-sectional imaging of thoracic and abdominal complications of cerebrospinal fluid shunt catheters.
    Bolster F; Fardanesh R; Morgan T; Katz DS; Daly B
    Emerg Radiol; 2016 Apr; 23(2):117-25. PubMed ID: 26610766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary study of shunt related death in paediatric patients.
    Bryant MJ; McEniery J; Walker DG; Campbell R; Lister B; Sargent P; Withers TK; Baker J; Guazzo E; Rossato R; Anderson D; Tomlinson F
    J Clin Neurosci; 2004 Aug; 11(6):614-5. PubMed ID: 15261232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Avoidable factors that contribute to the complications of ventriculoperitoneal shunt in childhood hydrocephalus.
    Choudhury AR
    Childs Nerv Syst; 1990 Sep; 6(6):346-9. PubMed ID: 2257549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus.
    Tuli S; Drake J; Lawless J; Wigg M; Lamberti-Pasculli M
    J Neurosurg; 2000 Jan; 92(1):31-8. PubMed ID: 10616079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Childhood optic pathway tumors associated with ascites following ventriculoperitoneal shunt placement.
    West GA; Berger MS; Geyer JR
    Pediatr Neurosurg; 1994; 21(4):254-8; discussion 259. PubMed ID: 7865412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Brief Review of Ventriculoatrial and Ventriculopleural Shunts.
    Yerragunta T; Manda VS; Yerramneni VK; Reddy Kanala RN
    Neurol India; 2021; 69(Supplement):S476-S480. PubMed ID: 35103005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 8: Management of cerebrospinal fluid shunt infection.
    Tamber MS; Klimo P; Mazzola CA; Flannery AM;
    J Neurosurg Pediatr; 2014 Nov; 14 Suppl 1():60-71. PubMed ID: 25988784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Migration of the Distal Catheter of Ventriculoperitoneal Shunts in Pediatric Age Group: Case Series.
    Ezzat AAM; Soliman MAR; Hasanain AA; Thabit MA; Elshitany H; Kandel H; Abdel-Bari SH; Ghoul AMF; Abdullah A; Alsawy MFM; Ghaleb AA; Al Menabbawy A; Marei AA; El Razik BA; Schroeder HWS; Marx S; Zohdi A; El Refaee E
    World Neurosurg; 2018 Nov; 119():e131-e137. PubMed ID: 30031953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with early shunt revision within 30 days: analyses from the National Surgical Quality Improvement Program.
    Alvi MA; Bhandarkar AR; Daniels DJ; Miller KJ; Ahn ES
    J Neurosurg Pediatr; 2022 Jan; 29(1):21-30. PubMed ID: 34624850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.